Sino Biopharmaceutical Limited
SBMFF
$0.9891
$0.03914.12%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | 131.93% | 128.42% | -- |
| Total Depreciation and Amortization | -- | -- | -21.72% | -22.91% | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | -155.57% | -154.73% | -- |
| Change in Net Operating Assets | -- | -- | -- | -- | -- |
| Cash from Operations | -- | -- | 11.52% | 9.83% | -- |
| Capital Expenditure | -- | -- | 47.70% | 48.49% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 11.34% | 12.68% | -- |
| Cash from Investing | -- | -- | 51.53% | 52.27% | -- |
| Total Debt Issued | -- | -- | -38.57% | -38.57% | -- |
| Total Debt Repaid | -- | -- | 32.25% | 32.25% | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -53.39% | -53.39% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -22.11% | -22.11% | -- |
| Cash from Financing | -- | -- | 1.86% | 3.35% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -70.04% | -70.49% | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | 45.21% | 46.04% | -- |